SUN PHARMA ADV

The current price of SPARC is 332.55 INR — it has decreased by 5.00% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange SUN PHARMA ADV stocks are traded under the ticker SPARC.

SPARC stock is 5.26% volatile and has beta coefficient of 0.67. Check out the list of the most volatile stocks — is SUN PHARMA ADV there?

Yes, you can track SUN PHARMA ADV financials in yearly and quarterly reports right on TradingView.

SPARC stock has fallen by 18.54% compared to the previous week, the month change is a 7.63% fall, over the last year SUN PHARMA ADV has showed a 70.58% increase.

SPARC net income for the last quarter is ‪−996.50 M‬ INR, while the quarter before that showed ‪−864.20 M‬ INR of net income which accounts for −15.31% change. Track more SUN PHARMA ADV financial stats to get the full picture.

No, SPARC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, SPARC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUN PHARMA ADV stock right from TradingView charts — choose your broker and connect to your account.

SPARC reached its all-time high on Mar 10, 2015 with the price of 593.85 INR, and its all-time low was 35.15 INR and was reached on Dec 15, 2008.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 579.00 employees. See our rating of the largest employees — is SUN PHARMA ADV on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUN PHARMA ADV technincal analysis shows the strong sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUN PHARMA ADV stock shows the buy signal. See more of SUN PHARMA ADV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUN PHARMA ADV EBITDA is ‪−3.86 B‬ INR, and current EBITDA margin is −88.73%. See more stats in SUN PHARMA ADV financial statements.